awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34781699-44B1845D-B0F4-4A53-824D-2DE686BE745B
Q34781699-44B1845D-B0F4-4A53-824D-2DE686BE745B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34781699-44B1845D-B0F4-4A53-824D-2DE686BE745B
A phase II trial of brivanib in recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study.
P2860
Q34781699-44B1845D-B0F4-4A53-824D-2DE686BE745B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34781699-44B1845D-B0F4-4A53-824D-2DE686BE745B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
649446591fd10be9b28a96e6f845482925041755
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.